About 600 reports

(hepatitis A + hepatitis B + hepatitis E) vaccine

  • Hepatitis
  • World
  • India
  • China
  • Drug Approval

Hepatitis B

  • Hepatitis
  • World
  • China
  • Shaanxi
  • Guangdong
  • Pharmaceutical Registrations
  • Manufacturing Output

(hepatitis A + hepatitis B + hepatitis E) vaccine

  • Hepatitis
  • World
  • China
  • India
  • Drug Approval

Hepatitis C

  • Hepatitis
  • United States
  • China
  • Drug Approval
  • Stem Cell Transplantation

Hepatitis Drugs Exports

  • Hepatitis
  • China
  • Industrial Production
  • Labour Force

Hepatitis C

  • Hepatitis
  • China
  • Pharmaceutical Registrations
  • Prescription Drug Sales

hepatitis D vaccine

  • Hepatitis
  • World
  • Drug Approval
  • Dropout Rate

hepatitis C vaccine

  • Hepatitis
  • World

Table ##: AtomoRapid - Hepatitis C - Product Description

  • Hepatitis
  • Clinical Trial
  • World
  • South Africa
  • Direct Sales
  • Prescription Drug Sales

hepatitis D vaccine

  • Hepatitis
  • World
  • Drug Approval
  • Dropout Rate

Hepatitis C

  • Hepatitis
  • World

Abstract: - Global Hepatitis Therapeutics Market to Reach $25.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hepatitis Therapeutics estimated at US$21.1 Billion in the year 2020, is projected to reach a revised size of US$25.8 Billion by 2027, growing at a CAGR of 2.9% over the analysis period...

  • Hepatitis
  • World
  • China
  • United States

Chronic Hepatitis B (CHB)

  • Hepatitis
  • World
  • Infectious Disease Prevalence
  • Vaccination Coverage

“Hepatitis C - Pipeline Insight, 2021,” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Hepatitis C pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and...

  • Hepatitis
  • World

Abstract: - Global Hepatitis B Vaccines Market to Reach $1.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hepatitis B Vaccines estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at aCAGR of 3.3% over the period 2020-2027. Mono Vaccines,...

  • Hepatitis
  • World
  • China
  • United States

Abstract: - Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $5.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing...

  • Hepatitis
  • HIV AIDS
  • Diagnostics
  • World
  • China
  • United States

Table ##: Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Description

  • Hepatitis
  • Clinical Trial
  • World
  • India
  • Prescription Drug Sales
  • Drug Approval

Hepatitis B - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B – Pipeline Review, H1 2020, provides an overview of the Hepatitis B (Infectious Disease) pipeline landscape. Hepatitis B is a potentially life-threatening liver...

  • Hepatitis
  • Infectious Disease
  • World

‘Hepatitis D Virus (HDV) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted HDV epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Hepatitis D Virus (HDV) Understanding Hepatitis...

  • Hepatitis
  • Epidemiology
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Infectious Disease Prevalence

‘Chronic Hepatitis B Virus (CHB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted CHB epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Chronic Hepatitis B Virus (CHB) Understanding Chronic...

  • Hepatitis
  • United States
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

Hepatitis Therapeutics Market Report Overview Hepatitis Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hepatitis Therapeutics market types and applications. It is a focused study on Hepatitis Therapeutics market space...

  • Hepatitis
  • World
  • Health Provider Density

Hepatitis Diagnostic Test Market Report Overview Hepatitis Diagnostic Test market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hepatitis Diagnostic Test market types and applications. It is a focused study on Hepatitis Diagnostic Test market...

  • Diagnostics
  • Hepatitis
  • World
  • Health Provider Density

Hepatitis C (HCV) Pipeline Overview The Q4 Hepatitis C (HCV) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Hepatitis C (HCV), provides an update on the mechanism of action and targets, licensing and collaboration...

  • Hepatitis
  • China
  • World

Hepatitis B

  • Hepatitis
  • Clinical Trial
  • China
  • Japan
  • United States
  • Drug Approval
  • Prescription Drug Sales

‘Hepatitis C Virus (HCV) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted HCV epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Hepatitis C Virus (HCV) Understanding Hepatitis...

  • Hepatitis
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

Table ##: PKL PPC - HEPATITIS - HBCAB - Product Description

  • Hepatitis
  • Clinical Trial
  • World
  • Europe
  • Direct Sales
  • Prescription Drug Sales

Hepatitis Diagnostic Test Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Hepatitis Diagnostic Test market including the COVID-19 pandemic implications...

  • Diagnostics
  • Hepatitis
  • APAC
  • Central America

"Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Hepatitis D. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products...

  • Hepatitis
  • World
  • United States
  • Health Expenditure

United States Vaccine Market By Type (Influenza, Retrovirus, Hepatitis, Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV), Products and Pipeline, Companies The average human life span has grown significantly primarily due to vaccination. Vaccines have transformed public health...

  • Vaccine
  • Hepatitis
  • United States

Hepatitis Diagnostic Test Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Hepatitis Diagnostic Test Market Size, Outlook and Growth Opportunities to 2025: By Test Type (Blood Tests, Imaging Test, and Liver Biopsy) and By Region Hepatitis Diagnostic Test market outlook to 2025 report includes...

  • Diagnostics
  • Hepatitis
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure